Annexin Pharmaceuticals AB (publ) filed its Annual on Apr 19, 2023 for the period ending Dec 31, 2022. In this report its auditor, Öhrlings PricewaterhouseCoopers AB, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.297 SEK | +2.41% | +10.00% | +14.23% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.23% | 9.39M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ANNX Stock
- News Annexin Pharmaceuticals AB
- Annexin Pharmaceuticals AB Auditor Raises 'Going Concern' Doubt